Walgreens Boots Alliance Inc (WBA) Shares Sold by Icon Advisers Inc. Co.

Icon Advisers Inc. Co. lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 92.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,700 shares of the pharmacy operator’s stock after selling 90,400 shares during the quarter. Icon Advisers Inc. Co.’s holdings in Walgreens Boots Alliance were worth $559,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Pathstone Family Office LLC increased its holdings in shares of Walgreens Boots Alliance by 226.6% in the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares during the last quarter. Hudock Capital Group LLC increased its holdings in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the last quarter. Westside Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares during the last quarter. Zions Bancorporation increased its holdings in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares during the last quarter. Finally, Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the third quarter valued at approximately $135,000. 61.57% of the stock is owned by institutional investors and hedge funds.

In other Walgreens Boots Alliance news, insider Stefano Pessina acquired 98,858 shares of the stock in a transaction that occurred on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 14.80% of the company’s stock.

Several equities research analysts recently commented on WBA shares. Pivotal Research cut their price target on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, October 24th. Deutsche Bank started coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 price target for the company. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price target for the company in a report on Saturday, January 13th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $88.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. Eleven research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $85.53.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $68.46 on Tuesday. The firm has a market capitalization of $67,820.00, a P/E ratio of 18.91, a P/E/G ratio of 1.16 and a beta of 1.18. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.10 earnings per share. analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.

Walgreens Boots Alliance declared that its board has approved a stock repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a $0.40 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.34%. Walgreens Boots Alliance’s payout ratio is 44.20%.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://sportsperspectives.com/2018/02/13/walgreens-boots-alliance-inc-wba-shares-sold-by-icon-advisers-inc-co.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply